Categories:
COVID-19,
Association Advisories & Comments,
Heart News,
Stroke News & Brain Health,
Scientific Advisories, Statements, Guidelines
|
Published: March 17, 2020
Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician
Statement from the American Heart Association, the Heart Failure Society of America and the American College of Cardiology